Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Advertise in Pharma in Focus

Advertising in Pharma in Focus delivers you:

  • Unique access to a $17 billion industry
  • High visibility with over 11,500 readers every working day
  • Great reaction with high click through rates
  • Unparalled contact via unique beyond-the-click services

For more information, ring 02 9938 4381

Approvals Action
Pfizer antibiotic sees first generic
Southern Cross has added the first copy of a Pfizer antibiotic to the ARTG in a week which saw a flurry of generic activity.
Pipeline Monitor
Lilly, Amgen rev up major drugs
Lilly's Taltz and Amgen's Repatha both won significant extensions from the FDA this week as the companies attempt to build blockbuster futures out of their pipelines.
Perspective
Big city moves not just about the view
Moves by pharma companies to leave suburban sites for slick new city offices is as much about how they want to be seen as it is about the scenery.